B

Zhiyi Zhuo1,2,3, Junfei Wang1,2,3, Yonglei Zhang1,2,3

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 197 Ruijin Er Road, Shanghai 200025, P. R. China.

概括

替代拼接 (AS) 失调影响B细胞急性淋巴细胞白血病 (B-ALL) 的进展和治疗耐药性. 一个新的18-AS签名预测患者的结果,并确定个性化B-ALL管理的治疗点.